← Leaderboards
Joseph Kim
Beckman Research Institute/City Of Hope
$727,770
Attributed
$727,770
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $191.7K · FY2009–23$200K$150K$100K$50K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$727,770 · 2
By mechanism
K22$575,100 · 1
R03$152,670 · 1
Top collaborators
No co-investigators on record.
Most similar at Beckman Research Institute/City Of Hope
Same institution · by research overlap
- Binghui Shen$21,743,081
- Zijie Sun$18,720,797
- Jacob M Berlin$850,104
- Beth Anne Osia$69,500
Others in their field
Top investigators on “Cell Line”
- David Heimbrook · Leidos Biomedical Research, Inc.$236,973,333
- Dennis R. Burton · Scripps Research Institute$203,685,614
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$177,001,772
- John M Lachin · George Washington University$118,672,444
- David M Nathan · Massachusetts Institute Of Technology$118,672,444
- Fred M Gordin · Social And Scientific Systems, Inc.$82,802,056
Research focus
Cell LineTissuesResponseIn VitroMalignant NeoplasmsPathway InteractionsMutationDuct (Organ) StructureDrug TestingEvaluationClinical ResearchCxcr4 Signaling PathwayCancer TherapyCxcl12 GeneCancer EtiologyCxcr4 GeneClinical TrialsCessation Of LifeChemokine ReceptorChemopreventionCancer ModelAllelesAmd3100Co-Immunoprecipitations
Grant awards (5)
Alterations in DNA Damage following Major Surgery and Hyperthermic Intraperitoneal Chemotherapy$76,331
R03 · FY2023 · CA · contact PI
Alterations in DNA Damage following Major Surgery and Hyperthermic Intraperitoneal Chemotherapy$76,339
R03 · FY2022 · CA · contact PI
CXCL12/CXCR4 Signaling - A Novel Target for Pancreatic Intraepithelial Neoplasia$191,700
K22 · FY2011 · CA · contact PI
CXCL12/CXCR4 Signaling - A Novel Target for Pancreatic Intraepithelial Neoplasia$191,700
K22 · FY2010 · CA · contact PI
CXCL12/CXCR4 Signaling - A Novel Target for Pancreatic Intraepithelial Neoplasia$191,700
K22 · FY2009 · CA · contact PI